Showing
1 - 4
results of
4
for search '
Bhor, M.
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Bhor, M.
Showing
1 - 4
results of
4
for search '
Bhor, M.
'
, query time: 0.05s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review
by
Lee S
,
Vania DK
,
Bhor
M
,
Revicki D
,
Abogunrin S
,
Sarri G
Published 2020-07-01
Get full text
Article
2
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
by
Tremblay G
,
Dolph M
,
Bhor
M
,
Said Q
,
Elliott B
,
Briggs A
Published 2018-11-01
Get full text
Article
3
For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports
by
Bhor
,
M
.
,
Birch, K.
,
Dennen, S.
,
Kanter, J.
,
Neumann, P.
,
Pednekar, P.
,
Shafrin, J.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
by
Tremblay G
,
Dolph M
,
Bhor
M
,
Said Q
,
Roy A
,
Elliott B
,
Briggs A
Published 2018-11-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Article
Cost-Benefit Analysis
Disease
Drug Therapy
Health Care Costs
Humans
Medical Oncology
Quality-Adjusted Life Years
Rare Diseases
United States
absenteeism
cardiovascular disease
caregiver burden
cost benefit analysis
cost effectiveness analysis
diabetes mellitus
diseases
drug cost
drug therapy
economics
evaluation study
funding
health care cost
health care quality
health care system
health equity
household
human
leisure
oncology
Loading...